Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON)

Joshua Tobias, Marina Maglakelidze, Zoran Andrić, Dinara Ryspayeva, Iurie Bulat, Ivan Nikolić, Zoran Petrović, Tanuj Chawla, Rajnish Nagarkar, Erika Garner-Spitzer, Christoph C. Zielinski, Leslie Mi Ok Chong, Bonnie Nixon, Nicholas J. Ede, Sharon Yavrom, Michael Kundi, Ursula Wiedermann

Open source

DOI: 10.1158/1078-0432.ccr-24-0742
Published: 2024-07-19
Container: Clinical Cancer Research
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-24-0742,
  title = {Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON)},
  author = {Joshua Tobias and Marina Maglakelidze and Zoran Andrić and Dinara Ryspayeva and Iurie Bulat and Ivan Nikolić and Zoran Petrović and Tanuj Chawla and Rajnish Nagarkar and Erika Garner-Spitzer and Christoph C. Zielinski and Leslie Mi Ok Chong and Bonnie Nixon and Nicholas J. Ede and Sharon Yavrom and Michael Kundi and Ursula Wiedermann},
  year = {2024},
  journal = {Clinical Cancer Research},
  doi = {10.1158/1078-0432.ccr-24-0742},
  url = {https://doi.org/10.1158/1078-0432.ccr-24-0742}
}

RIS

TY  - JOUR
TI  - Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON)
AU  - Joshua Tobias
AU  - Marina Maglakelidze
AU  - Zoran Andrić
AU  - Dinara Ryspayeva
AU  - Iurie Bulat
AU  - Ivan Nikolić
AU  - Zoran Petrović
AU  - Tanuj Chawla
AU  - Rajnish Nagarkar
AU  - Erika Garner-Spitzer
AU  - Christoph C. Zielinski
AU  - Leslie Mi Ok Chong
AU  - Bonnie Nixon
AU  - Nicholas J. Ede
AU  - Sharon Yavrom
AU  - Michael Kundi
AU  - Ursula Wiedermann
PY  - 2024
JO  - Clinical Cancer Research
DO  - 10.1158/1078-0432.ccr-24-0742
UR  - https://doi.org/10.1158/1078-0432.ccr-24-0742
ER  -

APA

Tobias, J., Maglakelidze, M., Andrić, Z., Ryspayeva, D., Bulat, I., Nikolić, I., Petrović, Z., Chawla, T., Nagarkar, R., Garner-Spitzer, E., Zielinski, C. C., Chong, L. M. O., Nixon, B., Ede, N. J., Yavrom, S., Kundi, M., & Wiedermann, U. (2024). Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON). Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-24-0742

Source records

crossref · retrieved 2026-09-26T09:31:48.259Z